IPSC

Century Therapeutics, Inc.NASDAQHealthcare

$2.13+2.82%ClosedMarket Cap: $184.4M

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-01-20	Piper Sandler	—	Overweight	—
2025-11-17	Leerink Partners	—	Market Perform	—
2025-05-16	Chardan Capital	—	Buy	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$-0.47	$3.7M	2
Sun Dec 31	$-0.43	$1.2M	2
Mon Dec 31	$-0.50	$375.0K	1
Tue Dec 31	$-0.39	$77.6M	1

IPSC | Century Therapeutics, Inc. Analyst Ratings & Price Target - InvestLog